Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-025986
Filing Date
2013-05-02
Accepted
2013-05-02 16:11:35
Documents
12
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v338717_10q.htm 10-Q 384500
2 EXHIBIT 10.1 v338717_ex10-1.htm EX-10.1 33053
3 EXHIBIT 10.2 v338717_ex10-2.htm EX-10.2 33174
4 EXHIBIT 31.1 v338717_ex31-1.htm EX-31.1 9031
5 EXHIBIT 31.2 v338717_ex31-2.htm EX-31.2 8747
6 EXHIBIT 32.1 v338717_ex32-1.htm EX-32.1 4412
  Complete submission text file 0001144204-13-025986.txt   3615932

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT acur-20130331.xml EX-101.INS 430526
8 XBRL TAXONOMY EXTENSION SCHEMA acur-20130331.xsd EX-101.SCH 44592
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20130331_cal.xml EX-101.CAL 33794
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20130331_def.xml EX-101.DEF 206877
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20130331_lab.xml EX-101.LAB 363530
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20130331_pre.xml EX-101.PRE 241487
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

EIN.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10113 | Film No.: 13808125
SIC: 2834 Pharmaceutical Preparations